NIM
CRBP icon

NEOS Investment Management’s Corbus Pharmaceuticals CRBP Stock Holding History

NEOS Investment Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25,486
Closed -$526K – 596
2024
Q3 		$526K Sell
25,486
-10,969
-30% -$561K 0.02% 485
2024
Q2 		$1.65M Buy
+36,455
New +$1.53M 0.07% 248

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NEOS Investment Management's CRBP Position: Q4 2024 in Review

NEOS Investment Management sold out of Corbus Pharmaceuticals (CRBP) in Q4 2024, closing a stake of 25,486 shares — an estimated $526K sold.

NEOS Investment Management first reported a position in CRBP in Q2 2024 and held it in 2 quarters. The position peaked at $1.65M in Q2 2024. 99 funds tracked by Wall St. Rank hold CRBP as of Q4 2024.

  • NEOS Investment Management reported no remaining Corbus Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • NEOS Investment Management sold 25,486 Corbus Pharmaceuticals shares in Q4 2024, an estimated $526K.
  • NEOS Investment Management first reported a position in Corbus Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • NEOS Investment Management's Corbus Pharmaceuticals position peaked at $1.65M in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2024.

Based on NEOS Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.